WisdomTree BioRevolution Fund
Not enough financial coverage to compute a composite score for WDNA. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.wisdomtree.com/investments/etfs/megatrends/wdna
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
- IPO
- 2021
- HQ
- New York, NY, US
Price Chart
Valuation
- Market Cap
- $2.29M
- Div Yield
- 4.38%
Performance & Tape
- 52W High
- $18.88
- 52W Low
- $12.27
- 50D MA
- $17.63
- 200D MA
- $16.90
- Beta
- 1.30
- Avg Volume
- 633
Get TickerSpark's AI analysis on WDNA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our WDNA Coverage
We haven't published any research on WDNA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate WDNA Report →